EBS PEER ANALYSIS

Emergent Biosolutions Inc — metric-by-metric comparison with peers and the industry median

EBSEmergent Biosolutions Inc

🇺🇸 USA · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

EBSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	EBS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
P/E	—	31.28●	—	—	46.82	—	21.37
P/B	0.89	1.98	0.33●	0.51	3.47	0.80	1.82
EV/EBITDA	5.70●	19.15	—	6.74	14.07	33.84	12.26
P/S	0.69	3.94	0.60●	0.70	1.86	5.03	2.09

Financial Health
Metric	EBS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
Current Ratio	4.29●	0.92	2.79	2.00	1.33	1.73	2.22
Debt/Equity	109.7%	52.3%	20.4%	23.1%	41.0%	5.9%●	46.3%
NetDebt/EBITDA	2.68	3.50	-0.07	0.89	1.10	-0.10●	1.24

Profitability
Metric	EBS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
Net Margin	-1.3%	12.6%●	-158.8%	-4.4%	4.0%	-3.6%	4.0%
ROE	-1.6%	6.3%	-63.6%	-3.6%	8.7%●	-0.6%	6.4%
ROA	-0.6%	3.2%	-49.7%	-2.5%	4.8%●	-0.5%	3.4%
EBITDA Margin	22.8%	25.2%●	-156.2%	12.0%	14.3%	14.8%	18.2%

Growth + Dividend
Metric	EBS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
Rev. Growth	-29.9%	-26.7%	3.8%	7.7%	16.3%●	-2.3%	7.5%
NI Growth	—	-14.2%	—	—	146.6%●	—	5.0%
Div. Yield	—	2.0%	—	0.0%	0.0%	2.6%●	2.0%
Payout	—	40.0%	—	0.0%	0.0%	-365.1%	0.8%

Valuation
Metric	EBS	EOLS	IRWD	ORGO	SIGA	AMPH	Ind. Median
P/E	—	—	7.06●	—	13.65	11.52	21.37
P/B	0.89	-15.63●	-3.32	0.79	1.82	1.18	1.82
EV/EBITDA	5.70	—	5.30	7.52	4.79●	6.81	12.26
P/S	0.69	1.49	2.00	0.59●	2.95	1.27	2.09

Financial Health
Metric	EBS	EOLS	IRWD	ORGO	SIGA	AMPH	Ind. Median
Current Ratio	4.29●	2.04	1.41	3.53	3.25	3.85	2.22
Debt/Equity	109.7%	-573.0%●	-275.1%	18.6%	0.4%	88.7%	46.3%
NetDebt/EBITDA	2.68	-8.20●	1.82	-0.57	-5.27	2.05	1.24

Profitability
Metric	EBS	EOLS	IRWD	ORGO	SIGA	AMPH	Ind. Median
Net Margin	-1.3%	-14.4%	28.3%●	-0.1%	21.6%	11.0%	4.0%
ROE	-1.6%	—	—	-0.1%	11.0%●	10.4%	6.4%
ROA	-0.6%	-20.0%	26.8%●	-0.1%	8.7%	4.8%	3.4%
EBITDA Margin	22.8%	-4.6%	57.3%●	7.3%	29.3%	26.6%	18.2%

Growth + Dividend
Metric	EBS	EOLS	IRWD	ORGO	SIGA	AMPH	Ind. Median
Rev. Growth	-29.9%	9.6%	13.8%●	11.9%	-22.1%	-1.1%	7.5%
NI Growth	—	—	—	—	-58.2%	-44.1%●	5.0%
Div. Yield	—	—	—	3.9%	15.6%●	—	2.0%
Payout	—	—	—	-4,093.3%	213.6%	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on EBS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.